MedTrace Logo

The Relationship Between Arsenic Methylation Capability and Blood Metals in Children With Developmental Delays

NCT02523989 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2015-08-14

No results posted yet for this study

Summary

The purpose of this study is to explore the relationship between arsenic methylation and blood metals in children with developmental delays and its correlation with health related quality of life.

Conditions

  • Developmental Delays

Interventions

OTHER

study group

Explore the relationship of heavy metals and health related quality of life, including the relationship between the developmental delays and polymorphism of arsenic methylation enzymes, arsenic methylation capability and blood metals. Identify the interaction of children function, health condition, and quality of life and arsenic methylation and blood metals in children with developmental delays.

Sponsors & Collaborators

  • Taipei Medical University

    lead OTHER

Principal Investigators

  • Ru-Lan Hsieh, MD · Visiting staff

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02523989 on ClinicalTrials.gov